Daiichi Life Insurance Co. Ltd. Invests $1.43 Million in Agilent Technologies, Inc. $A

Key Points

• Daiichi Life Insurance acquired 10,759 shares of Agilent Technologies in the second quarter, valued at approximately $1.43 million. Several other institutional investors also initiated positions.
• Analysts remain broadly positive, with a consensus “Moderate Buy” rating and an average price target of $160.24. Morgan Stanley raised its target to $175, while Bank of America upgraded the stock to “Buy.”
• Agilent reported quarterly EPS of $1.49, beating estimates of $1.41, while revenue rose 10% year over year to $1.83 billion. The stock opened at $159.25, near its 12-month high of $160.51.

Daiichi Life Insurance Co. Ltd. bought a new stake in Agilent Technologies, Inc. (NYSE:A - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 10,759 shares of the medical research company's stock, valued at approximately $1,429,000.

Several other institutional investors also recently bought and sold shares of A. Core Wealth Advisors LLC bought a new stake in Agilent Technologies in the fourth quarter valued at approximately $26,000. SHP Wealth Management purchased a new stake in shares of Agilent Technologies in the 4th quarter worth about $26,000. Navalign LLC bought a new stake in Agilent Technologies during the 4th quarter valued at approximately $27,000. Cedar Mountain Advisors LLC bought a new stake in shares of Agilent Technologies during the first quarter valued at approximately $27,000. Finally, MV Capital Management Inc. purchased a new stake in shares of Agilent Technologies in the 4th quarter worth about $28,000.

Analyst Upgrades and Downgrades

A has been the topic of several recent research reports. Bank of America upgraded Agilent Technologies from a "neutral" rating to a "buy" rating and cut their price target for the stock from $150.00 to $145.00 in a research note on Thursday, May 28th. Robert W. Baird raised their price target on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an "outperform" rating in a report on Tuesday, May 26th. Piper Sandler began coverage on Agilent Technologies in a research report on Thursday, June 11th. They set a "neutral" rating and a $150.00 price objective for the company. Morgan Stanley increased their price target on shares of Agilent Technologies from $160.00 to $175.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 12th. Finally, Royal Bank Of Canada initiated coverage on Agilent Technologies in a research report on Wednesday, May 27th. They set an "outperform" rating and a $153.00 price objective on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $160.24.

Agilent Technologies Trading Up 0.2%

A stock opened at $159.25 on Monday. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $160.51. The stock has a market capitalization of $44.98 billion, a price-to-earnings ratio of 31.98, a price-to-earnings-growth ratio of 2.80 and a beta of 1.25. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The firm's fifty day simple moving average is $137.57 and its two-hundred day simple moving average is $126.17.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping analysts' consensus estimates of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The firm had revenue of $1.83 billion during the quarter, compared to analysts' expectations of $1.80 billion. During the same period in the previous year, the company earned $1.31 EPS. The firm's revenue for the quarter was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, analysts anticipate that Agilent Technologies, Inc. will post 6.05 earnings per share for the current year.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source